Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies

Combination therapies

US Patent 10596165 · Granted Mar 24, 2020

Estimated economic value: $875,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating non-arteritic anterior ischemic optic neuropathy2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025
Treatment of cancer using a CD123 chimeric antigen receptor2023
Regulatable chimeric antigen receptor2023
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chim2022
Anti-BCMA chimeric antigen receptor2021
Methods of enhancing immune response2021
Methods of enhancing immune response2021
Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor2020
Treatment of cancer using a CD123 chimeric antigen receptor2020
Pharmaceutical combination of everolimus with dactolisib2020
Treatment of cancer using a CLL-1 chimeric antigen receptor2020